Florence P. van Hunsel, PharmD, PhD

Lead Safety Innovation
Netherlands Pharmacovigilance Centre Lareb, Netherlands

Florence van Hunsel, PharmD, PhD, is Lead Safety Innovation of the Netherlands Pharmacovigilance Centre Lareb. She has been working at Lareb since 2005. She is a Pharmacist and Epidemiologist with expertise in (statistical) signal detection, vaccine safety, causality assessment and patient involvement in pharmacovigilance. She is a member of the ISPE Vaccine SIG.

Poster(s):

• (062) Identifying Adverse Drug Reactions Through Knowledge Graph Modeling
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (093) Cohort event monitoring of COVID-19 vaccine safety using patient-reported outcomes in lactating women.
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (248) Cohort event monitoring of COVID-19 vaccine safety using patient-reported outcomes in pregnant women.
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (340) Differences in self-reported adverse events after the first mRNA COVID-19 vaccination between pregnant and non-pregnant women
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (BSPOT21) Changes in adverse event reporting of neurodevelopmental disorders after maternal valproate exposure, following a major scientific publication and regulatory decisions, a contribution of the ConcePTION project
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST